Mathiyazhagan Rengasamy

Efficacy and safety of adult human bone marrow-derived, cultured, pooled, allogeneic mesenchymal stromal cells (Stempeucel®): preclinical and clinical trial in osteoarthritis of the knee joint

Pawan Kumar Gupta, Anoop Chullikana, Mathiyazhagan Rengasamy et al. · Arthritis Research & Therapy · 2016 · 308 citations · Full text

Sphingolipid Metabolic Pathway: An Overview of Major Roles Played in Human Diseases

Raghavendra Pralhada Rao, Nanditha Vaidyanathan, Mathiyazhagan Rengasamy et al. · Journal of Lipids · 2013 · 186 citations · Full text

Administration of Adult Human Bone Marrow-Derived, Cultured, Pooled, Allogeneic Mesenchymal Stromal Cells in Critical Limb Ischemia Due to Buerger's Disease: Phase II Study Report Suggests Clinical Efficacy

Pawan Kumar Gupta, Murali Krishna, Anoop Chullikana et al. · Stem Cells Translational Medicine · 2016 · 76 citations · Full text

Preclinical safety & toxicity evaluation of pooled, allogeneic human bone marrow-derived mesenchymal stromal cells

Mathiyazhagan Rengasamy, Pawan Kumar Gupta, Udaykumar Kolkundkar et al. · The Indian Journal of Medical Research · 2016 · 39 citations · Full text

Transplantation of human bone marrow mesenchymal stromal cells reduces liver fibrosis more effectively than Wharton’s jelly mesenchymal stromal cells

Mathiyazhagan Rengasamy, Gurbind Singh, Noor Atiqah Fakharuzi et al. · Stem Cell Research & Therapy · 2017 · 39 citations · Full text